Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Sabrina Mackinnon.
Newcastle Authors
Title
Year
Full text
Linnea Blomgren
Dr Sabrina Mackinnon
Dr Arnaud Basle
Professor Wyatt Yue
Dr Thomas McCorvie
et al.
Dynamic inter-domain transformations mediate the allosteric regulation of human 5, 10-methylenetetrahydrofolate reductase
2024
Dr Sabrina Mackinnon
Professor Wyatt Yue
Luminescence-based complementation assay to assess target engagement and cell permeability of glycolate oxidase (HAO1) inhibitors
2024
Dr Sabrina Mackinnon
Professor Wyatt Yue
Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening
2022
Dr Sabrina Mackinnon
Professor Wyatt Yue
Fragment Screening Reveals Starting Points for Rational Design of Galactokinase 1 Inhibitors to Treat Classic Galactosemia.
2021
Dr Sabrina Mackinnon
Professor Wyatt Yue
Naturally occurring cobalamin (B
12
) analogs can function as cofactors for human methylmalonyl-CoA mutase
2021
Professor Wyatt Yue
Dr Sabrina Mackinnon
Succinyl-CoA:3-oxoacid coenzyme A transferase (SCOT) deficiency: A rare and potentially fatal metabolic disease
2021
Dr Sabrina Mackinnon
Expanding the genetic and phenotypic spectrum of branched-chain amino acid transferase 2 deficiency.
2019
Dr Sabrina Mackinnon
Substrate reduction therapy for inborn errors of metabolism.
2019
Dr Sabrina Mackinnon
Arginine does not rescue p.Q188R mutation deleterious effect in classic galactosemia
2018
Dr Sabrina Mackinnon
Dr Thomas McCorvie
Human Galactose-1-phosphate Uridylyltransferase (GALT), Galactokinase 1 (GALK1); A Target Enabling Package
2018
Dr Sabrina Mackinnon
Human Hydroxyacid Oxidase (HAO1); A Target Enabling Package
2018
Dr Sabrina Mackinnon
Dr Paul Brennan
Human alpha-aminoadipic semialdehyde synthase (AASS); A Target Enabling Package.
2017
Dr Sabrina Mackinnon
IDUA mutational profile and genotype-phenotype relationships in UK patients with Mucopolysaccharidosis Type I
2017